pear therapeutics closes financing prweb home news center blog united states united kingdom france login create a free account rss email newsletters put prweb on your site pear therapeutics closes financing share article funding round led by am ventures allows growing ehealth startup to build its portfolio of eformulations for mental and behavioral health we were very impressed by early data for eformulations™ in tackling mental health issues and pear’s approach provides an opportunity to elevate the standard of care for disorders going well beyond the brain boston ma prweb march   pear therapeutics the creator of prescription pharmaceuticalsoftware combination products called eformulations™ announced today that it has successfully closed on additional financing the funding round was led by am ventures with several undisclosed additional investors contributing capital the investment will allow pear to build a portfolio of eformulationstm concurrently andrew j schwab founding managing partner of am ventures has been appointed to the pear therapeutics board of directors pear is developing digital health interventions to enhance the efficacy of pharmaceutical preparations while its proprietary approach has broad clinical application the company is initially focused on disorders of the brain many of which impose large societal costs and yet still have limited treatment options “from mobile applications to virtual reality simulations to predictive analytics our technology directly boosts medication efficacy in incredibly significant ways well beyond enhanced compliance our team has pulled together the pieces required to deliver these products to patients” said corey mccann president and ceo of pear “brainrelated disorders represent a significant healthcare problem that today’s pharmaceutical pipeline is illequipped to address we were very impressed by early data for eformulations™ in tackling mental health issues and pear’s approach provides an opportunity to elevate the standard of care for disorders going well beyond the brain” said andrew j schwab about pear therapeutics pear therapeutics is a privately held ehealth company with offices in boston and san francisco developing drugsoftware combination products to address a broad range of severe conditions the company’s eformulationtm platform combines pharmaceutical preparations with userfriendly customizable and scientifically validated software applications pear’s patented approach provides better outcomes for patients smarter engagement and tracking tools for clinicians and costeffective solutions for payors for additional information please visit our website at httpwwwpeartherapeuticscom about am ventures am ventures actively invests in nextgeneration life science companies the firm is currently investing am ventures iv lp a  million venture capital fund that closed in  with over  million under management am has invested in  earlystage companies and its successful realizations include achaogen alexza pharmaceuticals dvs sciences sold to fluidigm envoy therapeutics sold to takeda flexion therapeutics ikaria sold to madison dearborn ilypsa sold to amgen incline therapeutics sold to the medicines company marcadia sold to roche miikana therapeutics sold to entremed panomics sold to affymetrix pearl therapeutics sold to astrazeneca relypsa semprus sold to teleflex and synosia therapeutics sold to biotie therapies for more information please visit httpwwwamventurescom share article on social media or email view article via pdf print contact author beth rogozinski pear therapeutics   email  matt smith pear therapeutics  email  visit website news center pear ventures opportunities iv llc  pooled investment fund hershenson formdscom  sec filings of fundraisings and investments in hedge funds private equity firms startups and growing companies formdscom newest filter local pear ventures opportunities iv llc industry pooled investment fund see others in industry address  high street palo alto ca 0phone   filings date filingtype reported sold incremental cash type exemptions link to raw filing 22 new 2 2 other b c c c sec link directors and executives current and past name role mar hershenson director pejman nozad director na na pear ventures opportunities management llc director bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright  2 · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version pear therapeutics scores  mln  pe hub subscribe to pe hub wire join over  of your peers get the mustread email for pevc professionals delivered to your inbox daily — for free us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions subscribe yes no registersign in a community for professionals in private capital pear therapeutics scores  mln february  2 by iris dorbian print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub pear therapeutics scores  mln boston and san franciscobased pear therapeutics a maker of digital therapies has raised  million in funding am ventures arboretum ventures and jazz venture partners led the round with participation from other investors that included bridge builders collaborative continue reading on pe hub writes boston and san franciscobased pear therapeutics a maker of digital therapies has raised  million in funding am ventures arboretum ventures and jazz venture partners led the round with participation from other investors that included bridge builders collaborative press release boston ma and san francisco ca prweb february 0 2 pear therapeutics pear the creator of prescription digital therapies called eformulations™ announced today that it has successfully closed on a m equity financing am ventures arboretum ventures and jazz venture partners led the round with participation from bridge builders collaborative and several additional investors the investment will allow pear to build and launch a portfolio of eformulations including reset™ and reseto™ pear’s digital therapies for treating substance use disorder sud “pear is at the forefront of a new field in medicine digital therapeutics and we are looking forward to working with the pear team along with our syndicate partners to pave the way forward for patients globally” said andy schwab cofounder and managing partner at am ventures pear is developing digital therapies called eformulations to treat disease and enhance the efficacy of pharmaceuticals pear validates the efficacy of these digital therapies by conducting randomized clinical trials and ultimately submitting the products for fda approval “by combining novel digital interventions with drugs pear has demonstrated the ability to enhance efficacy well beyond anything that is commercially available or in clinical development eformulations have the ability to quickly elevate the standard of care for many of the disorders of the brain and beyond” said corey mccann president and ceo of pear “from mobile applications to virtual reality to predictive analytics pear’s digital therapeutics platform directly boosts medication efficacy well beyond enhanced compliance the proof is ultimately in the clinical data and we are incredibly excited to back the pear team as they push toward fda approval and the delivery of these products to patients” said zack lynch general partner at jazz venture partners pear’s first products reset and reseto are proprietary digital therapies comprised of a patientfacing smartphone application and a clinicianfacing web interface that treat sud reset and reseto have been tested and validated in  randomized clinical studies involving more than  patients with sud in a pivotal randomized trial  patients seeking treatment for sud related to cocaine alcohol cannabis and stimulants across 0 treatment centers received either facetoface therapy or reset in lieu of therapist time patients receiving reset in lieu of therapist time demonstrated significantly higher rates of abstinence and higher rates of retention in treatment than patients receiving facetoface therapy alone the company plans to submit the digital therapeutic reset for fda approval in the first half of 2 pear has also developed reseto an eformulation that combines the reset modules with pharmacotherapy for opiate dependence in three separate randomized clinical trials involving over  patients reseto has shown the ability to enhance abstinence enhance retention in treatment and reduce required clinician intervention time in opiate dependence “given the dearth of treatment options for patients suffering from sud we are excited to launch reset and reseto these products have demonstrated clinical data supporting enhanced abstinence enhanced retention in treatment enhanced quality measures like addiction severity index asi and significantly reduced clinician intervention time enhancing efficacy while reducing costs is the holy grail for healthcare technology” said tim petersen managing director at arboretum ventures in addition to pear’s addiction products the company is launching on its platform a pipeline of eformulations for treating many of the disorders of the brain the company’s product targeting schizophrenia has already demonstrated patient usability and clinical efficacy in combination with multiple medications and is currently being examined in multiple largescale clinical trials involving patients with schizophrenia schizoaffective disorder and bipolar disorder pear has also developed products enhancing medications for treating chronic pain posttraumatic stress disorder ptsd general anxiety disorder gad major depressive disorder mdd and insomnia these products integrate into the pear platform a modular and secure cloudbased platform for pushing patientfacing interventions and collecting and displaying data to providers and payors about pear therapeutics pear therapeutics is a privately held ehealth company with offices in boston and san francisco the company develops digital therapies to address a broad range of severe conditions including addiction schizophrenia pain post­traumatic stress disorder anxiety depression and sleep pear’s eformulation™ platform combines pharmaceutical preparations with userfriendly customizable and scientifically validated software applications pear’s patented approach provides better outcomes for patients smarter engagement and tracking tools for clinicians and costeffective solutions for payors for additional information please visit our website at httpwwwpeartherapeuticscom about substance use disorder sud sud is a chronic relapsing disease impacting more than 2 million us individuals over the age of 2 every year sud results in over 0 deaths worldwide and the downstream consequences of sud are estimated to cost society more than  billion only  of individuals with sud in the us receive treatment with lack of access cited as a major barrier to receiving treatment more than  of us counties lack qualified clinicians to treat sud for patients who do receive care there is significant variability in quality frequency and utilization of evidencebased therapies across providers as well as discrepancies between research and realworld adherence to guidelines about am ventures founded in  am ventures actively invests in nextgeneration life science companies the firm is currently investing am ventures iv lp a  million venture capital fund that closed in  with  million under management am has invested in over  earlystage companies and its successful realizations include dvs sciences acquired by fluidigm envoy therapeutics acquired by takeda flexion therapeutics ikaria acquired by mallinckrodt ilypsa acquired by amgen incline therapeutics acquired by the medicines company marcadia acquired by roche novira acquired by jj pearl therapeutics acquired by astrazeneca and relypsa for more information please visit httpwwwamventurescom about arboretum ventures arboretum ventures is a venture capital firm specializing in the healthcare sector founded in  and located in ann arbor the firm manages 0 million in capital and has invested in more than  companies arboretum focuses on medical device diagnostic healthcare it and healthcare service companies that can achieve significant milestones and value creation in a capitalefficient manner more than simply a financial resource arboretum is a collaborative valueadded investor actively engaging our portfolio companies in strategy operations recruiting fundraising and exit planning arboretum’s guiding vision is to identify transformative healthcare companies that are developing improved and less costly solutions that address significant healthcare problems for more information please visit httpwwwarboretumvccom about jazz venture partners jazz venture partners invests in companies developing experiential technology that improve human performance at the intersection of digital consumer platforms such as virtual and augmented reality and neuroscience these companies are impacting health mindbody wellness peak mental and physical acuity accelerated learning and training sports and entertainment for more information please visit httpwwwjazzvpcom print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub pear therapeutics scores  mln boston and san franciscobased pear therapeutics a maker of digital therapies has raised  million in funding am ventures arboretum ventures and jazz venture partners led the round with participation from other investors that included bridge builders collaborative continue reading on pe hub writes find new deal opportunities supercharge your fundraising efforts and track top managers with vcj get your free trial or subscribe now sign up to our newsletter receive updates from our pe hub wire and top stories of the week newsletters first name last name email address us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions you are now subscribed to the pehub wire and top stories of the week newsletters buyouts insiderargosy group llc produces several free newsletters that are sent directly to the email you provide at registration namely pe hub wire pe hub canada wire pe hub wire top story of the week buyouts daily and vcj alert to enable us to keep providing these services free of charge we reserve the right to contact you with special invitations to sample or purchase private equityrelated products by submitting this free subscription request for any of these products you are also consenting to this communication should you ever wish to unsubscribe from a particular communication you may activate the unsubscribe mechanism at the bottom of the email this will discontinue both the special invitations mentioned previously as well as your subscription to the weekly newsletter the information you provide will be safeguarded by argosy group llcbuyouts insider the company’s subsidiaries may use it to keep you informed of relevant products and services we occasionally allow reputable companies outside of the company to mail details of products which may be of interest to you as an international group we may transfer your data on a global basis for the purposes indicated above we will never share your email or contact details with any outside company however should you have any questions please do not hesitate to contact us email protected top posts new oil and gas company native racks up 0 mln by iris dorbian bain capital double impact funds two companies by iris dorbian kkr to buy nature’s bounty from carlyle by luisa beltran blackrock leads funding round for fintech platform icapital by iris dorbian platinum equity to buy united site services by luisa beltran the pe hub podcast episode two by staff report private equity jobs of the week priceline kpmg novaquest are hiring by eamon murphy the carveout curveball by pehublogger network am ventures backs ehealth startup pear therapeutics  pe hub subscribe to pe hub wire join over  of your peers get the mustread email for pevc professionals delivered to your inbox daily — for free us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions subscribe yes no registersign in a community for professionals in private capital am ventures backs ehealth startup pear therapeutics march   by iris dorbian print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub am ventures backs ehealth startup pear therapeutics boston and san franciscobased ehealth startup pear therapeutics has secured an undisclosed amount of funding the lead investor was am ventures in conjunction with the funding andrew j schwab a managing partner at am ventures has been added to pear therapeutics board of directors continue reading on pe hub writes boston and san franciscobased ehealth startup pear therapeutics has secured an undisclosed amount of funding the lead investor was am ventures in conjunction with the funding andrew j schwab a managing partner at am ventures has been added to pear therapeutics’ board of directors press release boston ma prweb march   pear therapeutics the creator of prescription pharmaceuticalsoftware combination products called eformulations™ announced today that it has successfully closed on additional financing the funding round was led by am ventures with several undisclosed additional investors contributing capital the investment will allow pear to build a portfolio of eformulationstm concurrently andrew j schwab founding managing partner of am ventures has been appointed to the pear therapeutics board of directors pear is developing digital health interventions to enhance the efficacy of pharmaceutical preparations while its proprietary approach has broad clinical application the company is initially focused on disorders of the brain many of which impose large societal costs and yet still have limited treatment options “from mobile applications to virtual reality simulations to predictive analytics our technology directly boosts medication efficacy in incredibly significant ways well beyond enhanced compliance our team has pulled together the pieces required to deliver these products to patients” said corey mccann president and ceo of pear “brainrelated disorders represent a significant healthcare problem that today’s pharmaceutical pipeline is illequipped to address we were very impressed by early data for eformulations™ in tackling mental health issues and pear’s approach provides an opportunity to elevate the standard of care for disorders going well beyond the brain” said andrew j schwab about pear therapeutics pear therapeutics is a privately held ehealth company with offices in boston and san francisco developing drugsoftware combination products to address a broad range of severe conditions the company’s eformulationtm platform combines pharmaceutical preparations with userfriendly customizable and scientifically validated software applications pear’s patented approach provides better outcomes for patients smarter engagement and tracking tools for clinicians and costeffective solutions for payors for additional information please visit our website at httpwwwpeartherapeuticscom about am ventures am ventures actively invests in nextgeneration life science companies the firm is currently investing am ventures iv lp a  million venture capital fund that closed in  with over  million under management am has invested in  earlystage companies and its successful realizations include achaogen alexza pharmaceuticals dvs sciences sold to fluidigm envoy therapeutics sold to takeda flexion therapeutics ikaria sold to madison dearborn ilypsa sold to amgen incline therapeutics sold to the medicines company marcadia sold to roche miikana therapeutics sold to entremed panomics sold to affymetrix pearl therapeutics sold to astrazeneca relypsa semprus sold to teleflex and synosia therapeutics sold to biotie therapies for more information please visit httpwwwamventurescom print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub am ventures backs ehealth startup pear therapeutics boston and san franciscobased ehealth startup pear therapeutics has secured an undisclosed amount of funding the lead investor was am ventures in conjunction with the funding andrew j schwab a managing partner at am ventures has been added to pear therapeutics board of directors continue reading on pe hub writes find new deal opportunities supercharge your fundraising efforts and track top managers with vcj get your free trial or subscribe now sign up to our newsletter receive updates from our pe hub wire and top stories of the week newsletters first name last name email address us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions you are now subscribed to the pehub wire and top stories of the week newsletters buyouts insiderargosy group llc produces several free newsletters that are sent directly to the email you provide at registration namely pe hub wire pe hub canada wire pe hub wire top story of the week buyouts daily and vcj alert to enable us to keep providing these services free of charge we reserve the right to contact you with special invitations to sample or purchase private equityrelated products by submitting this free subscription request for any of these products you are also consenting to this communication should you ever wish to unsubscribe from a particular communication you may activate the unsubscribe mechanism at the bottom of the email this will discontinue both the special invitations mentioned previously as well as your subscription to the weekly newsletter the information you provide will be safeguarded by argosy group llcbuyouts insider the company’s subsidiaries may use it to keep you informed of relevant products and services we occasionally allow reputable companies outside of the company to mail details of products which may be of interest to you as an international group we may transfer your data on a global basis for the purposes indicated above we will never share your email or contact details with any outside company however should you have any questions please do not hesitate to contact us email protected top posts new oil and gas company native racks up 0 mln by iris dorbian bain capital double impact funds two companies by iris dorbian kkr to buy nature’s bounty from carlyle by luisa beltran blackrock leads funding round for fintech platform icapital by iris dorbian platinum equity to buy united site services by luisa beltran the pe hub podcast episode two by staff report private equity jobs of the week priceline kpmg novaquest are hiring by eamon murphy the carveout curveball by pehublogger network press archives  pear therapeutics skip to content about us what we do the pear team investors  partners products reset® for substance use disorder resetotm for opiate dependence thrivetm for schizophrenia recalltm for ptsd revivetm for generalized anxiety disorder press careers contact us press ← older posts utilizing software modules as an enhancement to pharmaceuticals for chronic conditions is poised to be critical component of digital healthcare october 0 2 new york ny–marketwired – oct  2 – psilos group in its seventh annual outlook outlining major emerging healthcare trends says digital therapeutics is a  billion market opportunity by 2 digital therapeutics — “software as a drug” — deploys software modules as an enhancement or even a substitute to a drug it is poised to become a critical component of digital health and to substantially improve the efficiency of american healthcare continue pear therapeutics ceo corey mccann md phd to speak at the th annual connected health symposium september  2 health technology research human behavior and public policy intersect at connected health symposium 2  over  visionaries leaders practitioners and thinkers will gather for the th year at this premier destination event hosted by partners healthcare connected health the th annual connected health symposium digital technology that cares bringing the human element to life october 2 2 at boston’s seaport hotel and world trade center continue     the largest and longest study of patients with schizophrenia interacting with digital therapeutics results released august 2 2 pear therapeutics to bring to market digital therapeutics based on clinical research from dr dror benzeev et al for patients with severe mental illness boston ma and san francisco ca – pear therapeutics pear the creator of prescription digital therapies called eformulationstm announced today results from a realworld implementation study examining a research version of thrivetm pear’s digital therapy for treating patients with serious mental illness including schizophrenia schizoaffective disorder and bipolar disorder continue pear’s substance use disorder therapy resettm featured in neurotech insights august  2 pear therapeutics advances the first regulated digital therapies for addiction pear therapeutics has grown significantly over the past year and now boasts forty employees split between the boston ma office and the san francisco ca location neuroinsights caught up with dr corey mccann founder and ceo to learn about pear’s progress developing digital therapeutics continue to fda or not to fda is hot topic at neurogaming conference may 2 2 by lesley mcclurg wandering through booths at a neurogaming conference in downtown san francisco this week was a little like finding myself in a science fiction infomercial this was the  the fourth annual experiential technology  neurogaming conference and expo where i mingled with neuroscientists and inventors eager to explain the technology behind their multiwired headsets or sleek brain gadgets continue pear therapeutics ceo corey mccann to speak at digital health summer summit may  2 the fifth annual digital health summer summit colocated this year with bio international convention at the moscone center in san francisco takes a deep dive into the elements of a successful digital health venture and showcases the latest digital health innovations from the industry’s most brilliant leaders and organizations who will explore the issues and opportunities facing the industry continue pear therapeutics closes  million financing february  2 boston ma and san francisco ca – pear therapeutics pear the creator of prescription digital therapies called eformulationstm announced today that it has successfully closed on a m equity financing am ventures arboretum ventures and jazz venture partners led the round with participation from bridge builders collaborative and several additional investors the investment will allow pear to build and launch a portfolio of eformulations including resettm and resetotm pear’s digital therapies for treating substance use disorder sud “pear is at the forefront of a new field in medicine digital therapeutics and we are looking forward to working with the pear team along with our syndicate partners to pave the way forward for patients globally” said andy schwab cofounder and managing partner at am ventures pear is developing digital therapies called eformulations to treat disease and enhance the efficacy of pharmaceuticals  pear validates the efficacy of these digital therapies by conducting randomized clinical trials and ultimately submitting the products for fda approval  “by combining novel digital interventions with drugs pear has demonstrated the ability to enhance efficacy well beyond anything that is commercially available or in clinical development  eformulations have the ability to quickly elevate the standard of care for many of the disorders of the brain and beyond” said corey mccann president and ceo of pear   “from mobile applications to virtual reality to predictive analytics pear’s digital therapeutics platform directly boosts medication efficacy well beyond enhanced compliance  the proof is ultimately in the clinical data and we are incredibly excited to back the pear team as they push toward fda approval and the delivery of these products to patients” said zack lynch general partner at jazz venture partners pear’s first products reset and reseto are proprietary digital therapies comprised of a patientfacing smartphone application and a clinicianfacing web interface that treat sud  reset and reseto have been tested and validated in  randomized clinical studies involving more than  patients with sud  in a pivotal randomized trial  patients seeking treatment for sud related to cocaine alcohol cannabis and stimulants across 0 treatment centers received either facetoface therapy or reset in lieu of therapist time  patients receiving reset in lieu of therapist time demonstrated significantly higher rates of abstinence and higher rates of retention in treatment than patients receiving facetoface therapy alone  the company plans to submit the digital therapeutic reset for fda approval in the first half of 2  pear has also developed reseto an eformulation that combines the reset modules with pharmacotherapy for opiate dependence in three separate randomized clinical trials involving over  patients reseto has shown the ability to enhance abstinence enhance retention in treatment and reduce required clinician intervention time in opiate dependence “given the dearth of treatment options for patients suffering from sud we are excited to launch reset and reseto  these products have demonstrated clinical data supporting enhanced abstinence enhanced retention in treatment enhanced quality measures like addiction severity index asi and significantly reduced clinician intervention time  enhancing efficacy while reducing costs is the holy grail for healthcare technology” said tim petersen managing director at arboretum ventures   in addition to pear’s addiction products the company is launching on its platform a pipeline of eformulations for treating many of the disorders of the brain  the company’s product targeting schizophrenia has already demonstrated patient usability and clinical efficacy in combination with multiple medications and is currently being examined in multiple largescale clinical trials involving patients with schizophrenia schizoaffective disorder and bipolar disorder  pear has also developed products enhancing medications for treating chronic pain posttraumatic stress disorder ptsd general anxiety disorder gad major depressive disorder mdd and insomnia  these products integrate into the pear platform a modular and secure cloudbased platform for pushing patientfacing interventions and collecting and displaying data to providers and payors about pear therapeutics pear therapeutics is a privately held ehealth company with offices in boston and san francisco  the company develops digital therapies to address a broad range of severe conditions including addiction schizophrenia pain posttraumatic stress disorder anxiety depression and sleep pear’s eformulationtm platform combines pharmaceutical preparations with userfriendly customizable and scientifically validated software applications  pear’s patented approach provides better outcomes for patients smarter engagement and tracking tools for clinicians and costeffective solutions for payors  for additional information please visit our website at wwwpeartherapeuticscom about substance use disorder sud sud is a chronic relapsing disease impacting more than 2 million us individuals over the age of 2 every year sud results in over 0 deaths worldwide and the downstream consequences of sud are estimated to cost society more than  billion only  of individuals with sud in the us receive treatment with lack of access cited as a major barrier to receiving treatment more than  of us counties lack qualified clinicians to treat sud for patients who do receive care there is significant variability in quality frequency and utilization of evidencedbased therapies across providers as well as discrepancies between research and realworld adherence to guidelines about am ventures founded in  am ventures actively invests in nextgeneration life science companies  the firm is currently investing am ventures iv lp a  million venture capital fund that closed in   with  million under management am has invested in over  earlystage companies and its successful realizations include dvs sciences acquired by fluidigm envoy therapeutics acquired by takeda flexion therapeutics flxn ikaria acquired by mallinckrodt ilypsa acquired by amgen incline therapeutics acquired by the medicines company marcadia acquired by roche novira acquired by jj pearl therapeutics acquired by astrazeneca and relypsa rlyp for more information please visit wwwamventurescom about arboretum ventures arboretum ventures is a venture capital firm specializing in the healthcare sector founded in  and located in ann arbor the firm manages 0 million in capital and has invested in more than  companies  arboretum focuses on medical device diagnostic healthcare it and healthcare service companies that can achieve significant milestones and value creation in a capitalefficient manner more than simply a financial resource arboretum is a collaborative valueadded investor actively engaging our portfolio companies in strategy operations recruiting fundraising and exit planning arboretum’s guiding vision is to identify transformative healthcare companies that are developing improved and less costly solutions that address significant healthcare problems  for more information please visit wwwarboretumvccom about jazz venture partners jazz venture partners invests in companies developing experiential technology that improve human performance  at the intersection of digital consumer platforms such as virtual and augmented reality and neuroscience these companies are impacting health mindbody wellness peak mental and physical acuity accelerated learning and training sports and entertainment  for more information please visit wwwjazzvpcom video game designers tout games as prescription therapies november   inside the push for prescription video games to treat autism anxiety even alzheimer’s by rebecca robbins hundreds of patients with mental illness are signing up to test an unusual experimental treatment video games it’s part of a bold push by several companies led by two boston startups to secure permission from federal regulators to market their video games as medical therapies to be prescribed by physicians for conditions ranging from depression to autism to even perhaps alzheimer’s disease…   continue pear therapeutics advisor patrick j kennedy to speak at cambridge public library on thursday october   at pm october   harvard book store will welcome former congressman patrick j kennedy for a discussion of his book a common struggle a personal journey through the past and future of mental illness and addiction coauthored with stephen fried event details cambridge public library  broadway cambridge ma   pm event flyer pear therapeutics featured in latest issue of neurotech insights october   pear therapeutics ceo corey mccann md phd was interviewed during the rd european neurotech investing and partnering summit held on september 0 in geneva switzerland read full article here ← older posts intellectual ventures nav visit related sites    iv lab    global good   isf incubator   kymeta   terrapower   echodyne join us on facebook follow us on twitter follow us on linkedin license » our patents buy » our patents about us services  solutions inventions  patents inventors news  info job opportunities we believe that ideas are valuable everything that we do — whether purchasing patents from individuals and businesses or creating our own inventions — is aligned to building and growing an invention marketplace learn more about us blog march 2  top nine invention stories from march march marks women’s history month and international women’s day celebrations around the world at intellectual ventures we commend the contributions of women to the field of invention and work to support more women and girls to pursue careers in stem blog march   failing for success alexander graham bell march marks the quick succession of two important anniversaries in the life of alexander graham bell and though we think of his invention as one that changed the course of history success for bell wasn’t always smooth video   think again what is invention at intellectual ventures we believe invention sparks progress and inspires the inquisitive spurring the bold and brave to explore uncharted territory in the pursuit of a better tomorrow inventor spotlight   merja holma learn how merja invented a cattle feed supplement thats revolutionizing the dairy industry the brainstorming sessions with iv are very productive it has been very fruitful to discuss with other scientists from other areas contact us blog customer login terms and conditions    privacy policy    site feedback copyright   intellectual ventures management llc iv® all rights reserved navigate our site license our patents buy our patents partner with us to invent services  solutions inventions  patents inventors news  info job opportunities × iv international australianew zealand canada china india ireland japan korea singapore taiwan united states × find jobs  intellectual ventures careers join us on facebook follow us on twitter about us services  solutions inventions  patents inventor network news  info job opportunities license » our patents sell » your patents job opportunities meet iv find your fit apply home join us keywords location all locations united states  washington  bellevue wa united states  silicon valley job category select an optionadministrativebusiness developmentbusiness services and administrativeculinaryengineeringexecutivefinancehuman resourcesinformation technologyinternshipslegalcorporate affairsmarketingcommunicationsprproductprogram managementsalesacquisitionsscientificsoftwarewritingediting search  back to search page designer bellevue wa washington united states the cooking lab is the publisher of both modernist cuisine the art and science of cooking  and modernist cuisine at home 2 our interdisciplinary team in bellevue washington includes scientists development chefs and a full editorial department as well as business and marketing share with twitter facebook linkedin email this job description 02 food scientist bellevue wa washington united states the cooking lab is the publisher of both modernist cuisine the art and science of cooking  and modernist cuisine at home 2 our interdisciplinary team in bellevue washington includes scientists development chefs and a full editorial department as well as business and marketing share with twitter facebook linkedin email this job description 0 senior internal communications specialist bellevue wa washington united states intellectual ventures is looking for an internal communications specialist reporting to the director corporate communications this individual will be accountable for developing and executing iv’s internal communications strategy  a handson role qualified candidates will have proven share with twitter facebook linkedin email this job description 2 postdoctoral research scientist – multiscale disease transmission modeling bellevue wa washington united states the institute for disease modeling idm part of intellectual ventures’ global good program is a collaborative effort to simulate the eradication of infectious diseases using computer software the idm team is a highly dynamic organization with a work environment that is defined by innovation and share with twitter facebook linkedin email this job description 02 metamaterials scientist bellevue wa washington united states the invention science fund isf is developing a revolutionary technology based on optical holographic metasurfaces isf seeks a highly skilled motivated metamaterials scientist to lead efforts in optical metamaterials theory and simulations as part of the optical technologies program the share with twitter facebook linkedin email this job description 0 administrative assistant bellevue wa washington united states intellectual ventures “iv” is a privatelyheld invention investment company based in bellevue washington intellectual ventures is the leader in the business of invention driven by the belief that invention sparks progress intellectual ventures is committed to creating and sustaining a market share with twitter facebook linkedin email this job description 0 research economist – global health bellevue wa washington united states the institute for disease modeling idm part of intellectual ventures’ global good program is a collaborative effort to simulate the eradication of infectious diseases using computer software the idm team is a highly dynamic organization with a work environment that is defined by innovation and share with twitter facebook linkedin email this job description  engineering director silicon valley united states intellectual ventures is looking for a seasoned engineer director with deep knowledge of hardware or software to develop expert case material participate in asset evaluation and define technical strategies for portfolio development and monetization   reporting to the vp of engineering share with twitter facebook linkedin email this job description 0 already a user please login terms and conditions    privacy policy    site feedback copyright  2 intellectual ventures management llc iv® all rights reserved marathon ventures inc  contact us home search explore marathon ventures intro video our history   about us letter from the president informational videos news facility —  contact us our brands   hermans nut house   retail product list product packaging product merchandising   food service product list   bulk product list   pears gourmet   retail product list product packaging product merchandising ecommerce   maggies gourmet popcorn retail product list product packaging product merchandising   la casa de botanas retail product list product packaging product merchandising   better together product packaging   river city roasters product merchandising   sun kernels business to business food service private label bulk direct store delivery   corporate gifts signature custom gift tins custom corporate programs direct to consumer our retailers the fresh roast store shop pearsgourmetcom  nuts coffee  gift tins   shop pears gourmet coffee decaf coffee exclusive blends  origins coffee flavored coffee   shop hermans nut house almonds cashews nut mixes peanuts pecans pistachios seeds  kernels specialty nuts walnuts login login contact us marathon ventures is centrally located in the heartland of the united states 0 ft crook rd nbellevue ne  2  phone2  toll free2  fax from hwy us  south   take the chandler rd exit toward ft crook rd turn left onto chandler rd w slight right onto ft crook rd n our facility is located on the east side of ft crook rd n next to no frills supermarket     to contact marathon ventures via email please complete the form below  it is our goal to return a response to your inquiry within 2 hours of your request mondayfriday copyright   marathon ventures inc eat drink share hermans nut house pears gourmet maggies gourmet popcorn better together river city roasters la casa de botanas house of snacks sun kernels pop kernels and eat drink share are registered trademarks of marathon ventures inc all rights reserved   marathon ventures inc  home —  home search explore marathon ventures intro video our history   about us letter from the president informational videos news facility contact us our brands   hermans nut house   retail product list product packaging product merchandising   food service product list   bulk product list   pears gourmet   retail product list product packaging product merchandising ecommerce   maggies gourmet popcorn retail product list product packaging product merchandising   la casa de botanas retail product list product packaging product merchandising   better together product packaging   river city roasters product merchandising   sun kernels business to business food service private label bulk direct store delivery   corporate gifts signature custom gift tins custom corporate programs direct to consumer our retailers the fresh roast store shop pearsgourmetcom  nuts coffee  gift tins   shop pears gourmet coffee decaf coffee exclusive blends  origins coffee flavored coffee   shop hermans nut house almonds cashews nut mixes peanuts pecans pistachios seeds  kernels specialty nuts walnuts login login      in  herman mirowitz with nothing more than an idea and hard work started a company based on the philosophy of providing great products and great service herman’s strong work ethic and business philosophy served the company well through the years as the guiding principles fueling our company growth and diversification today marathon ventures inc is a fullservice food and beverage processingmanufacturing packaging and marketing company  located in the heartland of the united states in omaha nebraska we are excited to be serving businesses and consumers across the entire country in addition to serving our business to business clients via our private label contract packaging contract manufacturing and food service business segments marathon ventures inc maintains a growing family of direct to consumer brands in a variety of categories including nuts coffee popcorn fruit and candy                                                                                                                                                                                                                                         while our website provides a good introduction to the range of products and services we are capable of providing don’t hesitate to contact us directly to discover how we can satisfy your specific business needs   copyright   marathon ventures inc eat drink share hermans nut house pears gourmet maggies gourmet popcorn better together river city roasters la casa de botanas house of snacks sun kernels pop kernels and eat drink share are registered trademarks of marathon ventures inc all rights reserved